Diagnosis, etiology, and therapy of fibromyalgia

Comprehensive Therapy

Volumn 25, Issue 4, 1999, Pages 221-227

  Dennis, Ang ^b   Wilke, William S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Desk A50 ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; FLUOXETINE;

ARTICLE; CLINICAL FEATURE; COMORBIDITY; DIAGNOSTIC APPROACH ROUTE; DISEASE CLASSIFICATION; FATIGUE; FIBROMYALGIA; HUMAN; MYALGIA; RHEUMATIC DISEASE; SLEEP DISORDER; SOCIOECONOMICS; TREATMENT PLANNING; WORK DISABILITY;

EID: 0345593462     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02889623     Document Type: Article

References (66)

1. Martinez JE, Ferraz MB, Sato EI, et al. Fibromyalgia versus rheumatoid arthritis: a longitudinal comparison of the quality of life. J Rheumatol. 1995;22(2):270-274.
2. Hadler NM. The dangers of the diagnostic process: iatrogenic labeling as in the fibrositis paralogism. In: Hadler NM, ed. Occupational Musculoskeletal Disorders. New York: Raven Press; 1993:16-33.
3. Wilke WS. Fibromyalgia: more than a label. Cleve Clin J Med. 1996;63:87-89.
4. Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL, et al. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum. 1997;40:1560-1570.
5. Gustafsson M, Gaston-Johannson F. Pain intensity and health locus of control: a comparison of patients with fibromyalgia and rheumatoid arthritis. Patient Educ Counseling. 1996;29(2):179-188.
6. Moldofsky H, Scarisbrick P, England R, Smythe H. Musculoskeletal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med. 1975;37:341-351.
7. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum. 1990;33:19-31.
8. Fibromyalgia: the Copenhagen declaration. Lancet. 1992; 340:663-664.
9. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum. 1990;33:160-172.
10. Wolfe F. Fibromyalgia: the clinical syndrome. Rheum Dis Clin North Am. 1989;15:1-18.
11. Wolfe F, Cathey MA, Kleinheksel SM. Fibrositis (fibromyalgia) in rheumatoid arthritis. J Rheumatol. 1984;11:814-818.
12. Wolfe F, Cathey MA, Klienheksel SM, et al. Psychological status in primary fibrositis and fibrositis associated with rheumatoid arthritis. J Rheumatol. 1984;11:500-506.
13. Yunus MB, Masi AT, Caalabro JJ, et al. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum. 1981;11:151-171.
14. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38:19-28.
15. Wolfe F. The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis. 1997;56:268-271.
16. Croft P, Schollum J, Silman A. Population study of tender point counts and pain as evidence of fibromyalgia. BMJ. 1994;309:696-699.
17. Moldofsky H, Scarisbrick P. Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom Med. 1976;38:35-44.
18. Moldofsky H. Sleep and fibrositis syndrome. Rheum Dis Clin North Am. 1989;15:91-103.
19. Wolfe F, Russell RJ, Vipraio G, Ross K, Anderson J. Serotonin levels, pain thresholds and fibromyalgia symptoms in the general population. J Rheumatol. 1997;24:555-559.
20. Russell IJ. Neurohormonal: abnormal laboratory findings related to pain and fatigue in fibromyalgia. J Musculoskel Pain. 1995;3:59-65.
21. Russell IJ, Orr MD, Liftman B, Vipraio GA, Alboukerk D, Michalek JE, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum. 1994;37:1593-1601.
22. Bradley LA, Alberts KR, Alarcon GS, Alexander MT, Mountz JM, Weigent DA, et al. Abnormal brain regional cerebral blood flow and cerebrospinal fluid levels of substance P in patients and non-patients with fibromyalgia (abstract). Arthritis Rheum. 1996;39(suppl 9):S212.
23. Hudson JI, Hudson MS, Pliner LF, Goldenberg DL, Pope HG Jr. Fibromyalgia and major affective disorders: a controlled phenomenology and family history study. Am J Psychiatry. 1985;142:441-446.
24. Boisset-Pioro MH, Esdaile JM, Fitzcharles M-A. Sexual and physical abuse in women with fibromyalgia syndrome. Arthritis Rheum. 1995;38:235-241.
25. Wilke WS, Mackenzie AH. Proposed pathogenesis of fibrositis. Cleve Clin Q. 1985;52(2):147-154.
26. Yunus MB. Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation (editorial). J Rheumatol. 1992;19(6): 846-850.
27. Griep EN, Boersma JW, de Kloet ER. Pituitary release of growth hormone and prolactin in the primary fibromyalgia syndrome. J Rheumatol. 1994;21:2125-2130.
28. Bennett RM, Clark SR, Campbell SM, Burckhardt CS. Low levels of somatomedin C in patients with the fibromyalgia syndrome. Arthritis Rheum. 1992;35:1113-1116.
29. Crofford LJ, Pillemer SR, Kalogeras KT, Cash JM, Michelson D, Kling MA, et al. Hypothalamic-pituitary-adrenal axis perturbation in patients with fibromyalgia. Arthritis Rheum. 1994;37:1583-1592.
30. Clauw DJ, Sabol M, Radulovic D, Wilson B, Katz P, Baraniuk J. Serum neuropeptides in patients with both FMS and chronic fatigue syndrome (abstract). J Musculoskel Pain. 1995;3(suppl 1):79.
31. Wilke WS, Fouad-Tarazi FM, Cash JM, Calabrese LH. The connection between chronic fatigue syndrome and neurally mediated hypotension. Cleve Clin J Med. 1998;65:261-265.
32. Yunus MB, Kalyan-Raman UP, Masi HE, Aldag JC. Electron microscopic studies of muscle biopsy in primary fibromyalgia syndrome: a controlled and blinded study. J Rheumatol. 1989;16:97-101.
33. Mountz JM, Bradley L, Modell J, Alexander R, Aaron L, Stewart K, et al. Fibromyalgia in women. Arthritis Rheum. 1995;38(7):926-938.
34. Sorensen J, Graven-Nielsen G, Henriksson KG, Bengtsson M, Arendt-Nielsen L. Hyperexcitability in fibromyalgia. J Rheumatol. 1998;25:152-155.
35. Mikkelsson M, Latikka P, Kautainen H, Isomeri R, Isomaki H. Muscle and bone pressure pain threshold and pain tolerance in fibromyalgia patients and controls. Arch Dis Phys Med Rehabil. 1992;73:814-818.
36. Wallace DJ, Schwartz E, Chi-Lin H, Peter JB. The "rule out lupus" rheumatology consultation: clinical outcomes and perspectives. J Clin Rheumatol. 1995;1:158-164.
37. Morand EF, Miller MH, Whittingham S, Littlejohn GO. Fibromyalgia syndrome and disease activity in systemic lupus erythematosus. Lupus. 1994;3:187-191.
38. Middleton JD, McFarland JE, Lipsky TE. The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum. 1994;37:1181-1188.
39. Gladman DD, Urowitz MD, Gaugh J, MacKinnon A. Fibromyalgia is a major contributor to quality of life in lupus. J Rheumatol. 1997;24:2145-2148.
40. Vitali C, Tavoni A, Neri R, Castriogiovanni P, Pasero G, Bombardieri S. Fibromyalgia features in patients with primary Sjögren's syndrome: evidence of a relationship with psychological depression. Scand J Rheumatol. 1989;18:21-27.
41. Buskila D, Gladman DD, Langvitz P, Urowitz, Smythe HA. Fibromyalgia in HIV infection. J Rheumatol. 1990;17(9): 1202-1206.
42. Wolfe F, Cathey MA, Kleinheksel SM. Fibrositis (fibromyalgia) in rheumatoid arthritis. J Rheumatol. 1994;11:814-818.
43. Langevitz P, Buskila D, Finkelstein R, et al. Fibromyalgia in familial Mediterranean fever. J Rheumatol. 1994;21:1335-1337.
44. Goodman SR, Vonfeldt JN, Callegari PE. The prevalence of fibromyalgia in osteoarthritis patients. Arthritis Rheum. 1995;38(suppl):R28.
45. Dinnerman H, Steere AC. Lyme disease associated with fibromyalgia. Ann Intern Med. 1992; 17:281-285.
46. Helfenstein M, Feldman D, Sato EI. Prevalence of the fibromyalgia syndrome (FS) in patients diagnosed as suffering from repetitive strain injuries (RSI). J Rheumatol. 1998; 25(suppl 52):15.
47. Petri M, Steckroth J. Fibromyalgia, not active SLE, explains fatigue, HAQ scores, disability and depression scores. Arthritis Rheum. 1996;39(suppl):S68.
48. Wang B, Gladman DD, Urowitz MB. Fatigue in lupus is not correlated with disease activity. J Rheumatol. 1998;25:892-895.
49. Calvo-Alen J, Bastian HM, Straton KV, Burgard SL, Mikhail IS, Alarcon GS. Identification of patient subsets among those presumptively diagnosed with, referred, and/or followed-up for systemic lupus erythematosus at a large tertiary care center. Arthritis Rheum. 1995;38:1475-1484.
50. Urrows S, Affleck G, Tennen H, Higgins P. Unique clinical and psychological correlates of fibromyalgia tender points and joint tenderness in rheumatoid arthritis. Arthritis Rheum. 1994;37:1513-1520.
51. Drosos AA, Andonopoulos AP, Lagos G, Angelopoulos NV, Moutsopoulos HM. Neuropsychiatric abnormalities in primary Sjögren's syndrome. Clin Exp Rheumatol. 1989;7:207-209.
52. Mauch E, Volk C, Kratzsch G, Krapf H, Kornhuber HH, Laufen H, Hummel KG. Neurological and neuropsychiatric dysfunction in primary Sjögren's syndrome. Acta Neurol Scand. 1994;89:31-35.
53. Smyth HA, Buskila B, Gladman DD. Performance of scored palpation, a point count, and dolorimetry in assessing unsuspecting non-articulate tenderness. J Rheumatol. 1993; 20:352-357.
54. Wilke WS. Treatment of "resistant" fibromyalgia. Rheum Dis Clin North Am. 1995;21(1):247-260.
55. Goldenberg DL. Treatment of fibromyalgia syndrome. Rheum Dis Clin North Am. 1989;15:61-67.
56. Granges G, Ziko P, Littlejohn GO. Fibromyalgia syndrome: assessment of the severity of the condition 2 years after diagnosis. J Rheumatol. 1994;21:523-529.
57. McCain GA, Bell DA, Mai F, et al. A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of the primary fibromyalgia syndrome. Arthritis Rheum. 1988;31:1135-1141.
58. Nichols DS, Glenn TM. Effects of aerobic exercise on pain perception, affect and level of disability in individuals with fibromyalgia. Phys Ther. 1994;74:327-332.
59. Carette S, McCain GA, Bell DA, et al. Evaluation of amitriptyline in primary fibrositis: a double blind, placebo-controlled study. Arthritis Rheum. 1986;29:655-659.
60. Jaeschke R, Adachi J, Guyatt G, et al. Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N of 1 randomized controlled trials. J Rheumatol 1991;18:447-451.
61. Quimby LG, Gratwick GM, Whitney CA, et al. A randomized trial of cyclobenzaprine for the treatment of fibromyalgia. J Rheumatol. 1989;16(suppl19):140-143.
62. Reynolds WJ, Moldofsky H, Saskin P, et al. The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia. J Rheumatol. 1991;18:452-454.
63. Goldenberg D, Mayskiy M, Mossey C, Ruthazer R, Schmid C. A randomized double blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum. 1996;39(11):1852-1859.
64. Burckhardt CS, Mannerkorpi K, Hedenberg L, et al. A randomized controlled clinical trial of education and physical training for women with fibromyalgia. J Rheumatol. 1994;21: 714-719.
65. Buckelew S, et al. The effects of biofeedback and exercise on fibromyalgia: a controlled trial. Arch Phys Med Rehabil. 1992;73:980.
66. Goldenberg DL, Kaplan KH, Nadeau MG, et al. A controlled study of a stress-reduction, cognitive-behavioral treatment program in fibromyalgia. J Musculoskel Pain. 1994;2:53-66.